This article has been updated to clarify the consumer-facing genetic testing models of Invitae and Color.
NEW YORK (GenomeWeb) – Patient advocates, researchers, and leading testing labs are disappointed with the US Preventive Services Task Force's draft recommendations on genetic testing for BRCA-related cancers for not reflecting the growing body of evidence that shows that a family history-focused screening strategy misses a significant swathe of the at-risk population.
Get the full story with
Premium Access
Only $95 for the
first 90 days*
Premium Access gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Try Premium Access now.
You may already have institutional access!
Check if I qualify.
Already a Precision Oncology News or 360Dx or GenomeWeb Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
